SCHEMBL3266715

SCHEMBL3266715

CC(=O)NNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 1/20 0.48
REN P00797 1/20 0.48
CTSS P25774 3/20 0.42
CTSL P07711 2/20 0.42
CTSK P43235 2/20 0.42
CTSB P07858 1/20 0.42
ATM Q13315 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CTRB1 P17538 1/20 0.41
ITGA4 P13612 1/20 0.41
ITGB7 P26010 1/20 0.41
AKT1 P31749 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
ABCB1 P08183 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3268342 0.87 GHSR (0.45) MMP13RENCTSSCTSLCTSK
SCHEMBL3273983 0.87 GHSR (0.45) MMP13RENCTSSCTSLCTSK
SCHEMBL4426560 0.86 REN (0.50) MMP13RENCTSSCTSLCTSK
SCHEMBL20516413 0.85 REN (0.48) MMP13RENCTSSCTSLCTSK
SCHEMBL20516414 0.85 REN (0.48) MMP13RENCTSSCTSLCTSK
SCHEMBL6600189 0.85 REN (0.49) MMP13RENCTSSCTSLCTSK
SCHEMBL3268094 0.85 REN (0.49) MMP13RENCTSSCTSLCTSK
SCHEMBL3268116 0.85 REN (0.49) MMP13RENCTSSCTSLCTSK
SCHEMBL8164713 0.84 REN (0.48) MMP13RENCTSSCTSLCTSK
SCHEMBL6602031 0.84 REN (0.44) MMP13RENCTSSCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506969-B1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS US INC (US) 2010-06-09 EP disclosed
EP-1506969-A1 Compounds with growth hormone releasing properties NOVO NORDISK A/S (DK) 2005-02-16 EP disclosed
EP-1047709-B1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK AS (DK) 2004-11-03 EP disclosed
US-6083908-A TREATING MEDICAL DISORDERS RESULTING FROM DEFICIENCY IN GROWTH HORMONE NOVO NORDISK A/S (DK) 2000-07-04 US disclosed